<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00180622</url>
  </required_header>
  <id_info>
    <org_study_id>SD-000-068</org_study_id>
    <nct_id>NCT00180622</nct_id>
  </id_info>
  <brief_title>Markers for COPD</brief_title>
  <official_title>Non-Invasive Markers for COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <brief_summary>
    <textblock>
      The primary aim of this study is to exploit a difference between COPD patients, chronic
      smokers without COPD and healthy non-smoking subjects. This will help to assess the utility
      of inflammatory and oxidative markers in exhaled air and sputum and to compare them with the
      lung function, clinical parameters and computerised tomography (CT).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2001</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>52</enrollment>
  <condition>Healthy Non-Smokers</condition>
  <condition>Current Smokers</condition>
  <condition>COPD Patients</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spirometry</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Exhaled Nitric Oxide and Carbon Monoxide</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Exhaled Breath Condensate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Induced Sputum</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CT Scan</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood test</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>St Georges Questionnaire</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bodypletysmography</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy non-smokers

          -  FEV1 &gt;80% predicted

          -  FEV1 reversibility of &lt;10% after inhaled (beta2-agonists

        Current smokers

          -  FEV1 no less than 80% predicted

          -  FEV1 reversibility of &lt;10% after inhaled (beta2-agonists

          -  Smoking history of &gt; 10 pack-years

        Moderate COPD

          -  FEV1 40-59% predicted

          -  FEV1 reversibility of &lt;10% after inhaled (beta2-agonists

          -  Smoking history of &gt; 10 pack-years**

        Severe COPD

          -  FEV1 &lt;40% predicted

          -  FEV1 reversibility of &lt;10% after inhaled (beta2-agonists

          -  Smoking history of &gt; 10 pack-years

        Exclusion Criteria:

          -  FEV1 increases by 200 ml and 15% of the baseline value after inhaled (beta2-agonists

          -  Asthma

          -  unstable disease (FEV1 &lt;35% predicted) and/or current, or within the last 4 weeks,
             respiratory tract infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergei A Kharitonov, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter J Barnes, MA DM DSc FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW3 6LY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>September 9, 2005</last_update_submitted>
  <last_update_submitted_qc>September 9, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2005</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
    <mesh_term>Carbon Monoxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

